State Street Corp Alkermes Plc. Transaction History
State Street Corp
- $2.25 Trillion
- Q2 2024
A detailed history of State Street Corp transactions in Alkermes Plc. stock. As of the latest transaction made, State Street Corp holds 9,215,058 shares of ALKS stock, worth $254 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
9,215,058
Previous 9,003,913
2.35%
Holding current value
$254 Million
Previous $244 Million
8.88%
% of portfolio
0.01%
Previous 0.01%
Shares
18 transactions
Others Institutions Holding ALKS
# of Institutions
346Shares Held
183MCall Options Held
209KPut Options Held
89.4K-
Black Rock Inc. New York, NY29.1MShares$801 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA20MShares$551 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA14.4MShares$395 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11MShares$303 Million0.03% of portfolio
-
Rtw Investments, LP New York, NY7.06MShares$194 Million2.84% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.52B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...